<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Int Soc Prev Community Dent</journal-id><journal-id journal-id-type="iso-abbrev">J Int Soc Prev Community Dent</journal-id><journal-id journal-id-type="publisher-id">JISPCD</journal-id><journal-title-group><journal-title>Journal of International Society of Preventive &#x00026; Community Dentistry</journal-title></journal-title-group><issn pub-type="ppub">2231-0762</issn><issn pub-type="epub">2250-1002</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25452931</article-id><article-id pub-id-type="pmc">4247554</article-id><article-id pub-id-type="publisher-id">JISPCD-4-63</article-id><article-id pub-id-type="doi">10.4103/2231-0762.144602</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Influence of aspirin on post-extraction bleeding &#x02013; A clinical study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Darawade</surname><given-names>Dattatraya A.</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Kumar</surname><given-names>Santosh</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib><contrib contrib-type="author"><name><surname>Desai</surname><given-names>Khushboo</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib><contrib contrib-type="author"><name><surname>Hasan</surname><given-names>Basit</given-names></name><xref ref-type="aff" rid="aff3">2</xref></contrib><contrib contrib-type="author"><name><surname>Mansata</surname><given-names>Anuj Vasantray</given-names></name><xref ref-type="aff" rid="aff4">3</xref></contrib></contrib-group><aff id="aff1">Department of Oral and Maxillofacial Surgery, Rungta College of Dental Sciences, Bhilai, Chattisgarh, India</aff><aff id="aff2"><label>1</label>Department of Periodontology, Karnavati School of Dentistry, Gandhinagar, Gujarat, India</aff><aff id="aff3"><label>2</label>Department of Conservative Dentistry and Endodontics, RKDF Dental College and Research Centre, Bhopal, Madhya Pradesh, India</aff><aff id="aff4"><label>3</label>Department of Oral and Maxillofacial Pathology, Karnavati School of Dentistry, Gandhinagar, Gujarat, India</aff><author-notes><corresp id="cor1"><bold>Corresponding author</bold> (e-mail: &#x0003c;<email xlink:href="dr.darawade@yahoo.com">dr.darawade@yahoo.com</email>&#x0003e;)
Dr. Dattatraya A. Darawade, Professor and Head, Department of Oral and Maxillofacial Surgery, Rungta College of Dental Sciences, Bhilai, Chattisgarh, India
</corresp></author-notes><pub-date pub-type="ppub"><month>11</month><year>2014</year></pub-date><volume>4</volume><issue>Suppl 1</issue><fpage>S63</fpage><lpage>S67</lpage><permissions><copyright-statement>Copyright: &#x000a9; Journal of International Society of Preventive and Community Dentistry</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>Aim:</title><p>The aim of the study was to evaluate the influence of aspirin on post-extraction bleeding in a clinical setup.</p></sec><sec id="st2"><title>Materials and Methods:</title><p>Two hundred patients aged between 50 and 65 years who were indicated for dental extraction for endodontic reason were selected from the outpatient Department of Oral and Maxillofacial Surgery. The patients were randomly divided into aspirin continuing group (group A) and aspirin discontinuing group (group B). After checking all the vital signs, the extractions were carried out. Bleeding time and clotting time were recorded for evaluation by Chi-square test.</p></sec><sec id="st3"><title>Results:</title><p>Chi-square test revealed that the bleeding time increased (3.8 &#x000b1; 0.75) in group A patients continued with the aspirin therapy where as group B discontinued aspirin. Similarly, the clotting time increased in group B patients and decreased in group A patients. But in both the groups, bleeding and clotting time remained within normal limits.</p></sec><sec id="st4"><title>Conclusion:</title><p>Reviewing most of the dental and medical literature, it can be concluded that there is absolutely no need to discontinue antiplatelet therapy for any ambulatory dental procedure, and even if the practitioner wishes to discontinue, it should not be for more than 3 daAQ2ys. This is also stated in the guidelines of the American Heart Association.</p></sec></abstract><kwd-group><kwd><italic>Antiplatelet drugs</italic></kwd><kwd><italic>aspirin</italic></kwd><kwd><italic>bleeding time</italic></kwd><kwd><italic>tooth extraction</italic></kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>INTRODUCTION</title><p>Medical practitioners commonly advice their patients who are on antiplatelet therapy to either stop or alter their medications prior to surgical procedures due to fear of excessive and uncontrolled bleeding. It is a proven fact that aspirin causes increased risk of intraoperative as well as postoperative bleeding and also increased risk of thromboembolic events such as myocardial infraction and cerebrovascular accidents if the drug is continued.[<xref rid="ref1" ref-type="bibr">1</xref>] Thrombotic and thromboembolic occlusion of blood vessels is the main cause of ischemic events in heart, lungs, and brain.[<xref rid="ref2" ref-type="bibr">2</xref>] In case of blood vessel injury, hemostatic mechanism is responsible for stopping the extravasation. Mainly hemostatic mechanisms are characterized by two consecutive phases: Primary and secondary. Primary mechanism arrests early bleeding as a result of platelet plug formation.[<xref rid="ref3" ref-type="bibr">3</xref>] The secondary hemostasis phase is mediated by a complex cascade of clotting factors which helps in the formation of fibrin clot.[<xref rid="ref4" ref-type="bibr">4</xref>] In recent years, lot of research has been done and progress has been made in the field of antiplatelet agents and anticoagulants. These drugs have been utilized for the management of arterial thrombosis also.[<xref rid="ref2" ref-type="bibr">2</xref>] Even though a number of antiplatelet and anticoagulant agents have been developed, aspirin and warfarin remain the standard drugs of choice.[<xref rid="ref5" ref-type="bibr">5</xref>]</p><p>Development of aspirin dates back to 1897 and is considered as one of the safest and cheapest drugs worldwide. A general practitioner Lawrence Craven prescribed low-dose aspirin (baby aspirin) to his 400 patients and none of them developed myocardial infraction.[<xref rid="ref6" ref-type="bibr">6</xref>] This was probably the first time in medical history where aspirin was used to prevent myocardial infarction. Since then, it has become the drug of choice for cardiologists.</p><p>The antithrombotic effect of aspirin is mediated by irreversible inhibition of cyclooxygenase activity in platelets. Phospholipase A2 acts on the cell membrane to release arachidonic acid on activation. Cyclooxygenase acts on arachidonic acid to produce thromboxane A2. Thromboxane A2 is a potent platelet stimulant which leads to degranulation of platelet and platelet aggregation. Aspirin inhibits cyclooxygenase enzyme and decreases the level of platelet stimulant thromboxane A2,[<xref rid="ref5" ref-type="bibr">5</xref>] thus increasing the bleeding time. This is the important reason for a medical practitioner to stop aspirin 3-7 days prior to any invasive surgery.</p><p>The purpose of this study was to investigate the influence of aspirin on post-extraction bleeding.</p></sec><sec sec-type="materials|methods" id="sec1-2"><title>MATERIALS AND METHODS</title><p>This study was conducted at the outpatient Department of Oral and Maxillofacial Surgery. Patients who were on aspirin therapy, aged between 50 and 65 years, and who had to undergo tooth extraction for endodontic reason with no mobility were selected for the study. Patients on warfarin, non-steroidal anti-inflammatory drugs, heparin, steroids, or suffering from blood disorders and diabetes were excluded from the study. Informed consent was obtained from the patients and the ethical committee clearance was also obtained.</p><p>Two hundred patients including both males and females whose teeth were indicated for extraction were included in the study. Patients were randomly divided into group A and group B of 100 patients each. Group A patients continued to receive aspirin preoperatively, while Group B patients were asked to stop aspirin 7 days prior to extraction after consultation with the physician.</p><p>Preoperatively, all the vital signs (blood pressure and pulse) were measured. Bleeding time (White and Lee technique) and clotting time (Ivy's technique) were calculated. Extractions were carried out only if the above parameters were within normal range. After atraumatic extraction (forceps method) was performed, the bleeding time was recorded. Analgesics and antibiotics were prescribed as needed for pain and infection control.</p><p>Chi-square test was used to evaluate the relative frequencies of patients in both groups. Differences of parametric variables were tested with analysis of variance.</p></sec><sec sec-type="results" id="sec1-3"><title>RESULTS</title><p>After applying Chi-square test, the mean bleeding time was calculated as 2.1 &#x000b1; 0.52 min in the patients who discontinued baby aspirin (group B) 7 days prior to extraction. Bleeding time of group A patients who continued aspirin through the entire study was found to be 3.8 &#x000b1; 0.75 min. This difference was statistically significant (<italic>P</italic> = 0.002) [<xref ref-type="table" rid="T1">Table 1</xref> and <xref ref-type="fig" rid="F1">Graph 1</xref>]. Although there was significant increase in the bleeding time of group A patients, it should be noted that the bleeding time of both the groups was within normal limits. Clotting time of group B patients was 3.8 &#x000b1; 0.75 min and group A patients was 4.7 &#x000b1; 0.52 min, which were also within the normal limits (normal range according to Ivy's method: 3-5 min).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Test statistics</p></caption><graphic xlink:href="JISPCD-4-63-g001"/></table-wrap><fig id="F1" position="float"><label>Graph 1</label><caption><p>Mean bleeding time and mean clotting time (in minutes) of group A and group B patients</p></caption><graphic xlink:href="JISPCD-4-63-g002"/></fig></sec><sec sec-type="discussion" id="sec1-4"><title>DISCUSSION</title><p>Historically, aspirin was used as an anti-inflammatory, analgesic, and antipyretic drug for a short period of disease activity. In 1950, Lawrence Craven reported for the first time its long-term use to prevent myocardial infarction.[<xref rid="ref6" ref-type="bibr">6</xref>] He advocated a lower dose for antiplatelet action. Antiplatelet activity of aspirin occurs at doses ranging from as low as 40 mg/day[<xref rid="ref7" ref-type="bibr">7</xref>] to 320 mg/day.[<xref rid="ref8" ref-type="bibr">8</xref>] Doses above 320 mg/day decrease the effectiveness of aspirin as an antiplatelet agent due to inhibition of prostacyclin production.[<xref rid="ref9" ref-type="bibr">9</xref>] However, recent clinical trial indicates that 160 mg/day is optimal for antiplatelet action.[<xref rid="ref10" ref-type="bibr">10</xref>] In emergencies where urgent antithrombotic action is required, a loading dose of 300 mg is advocated.[<xref rid="ref9" ref-type="bibr">9</xref>] Usually, in the United States, daily dose of 81 mg, 160 mg, or 325 mg is prescribed, while in Europe and other countries, daily dose of 75 mg, 150 mg, or 300 mg is prescribed.[<xref rid="ref10" ref-type="bibr">10</xref>]</p><p>Risk of continuing aspirin therapy prior to surgery is that with the alteration of platelet function, longer time period is required to stop bleeding from a surgical site. This is attributed to the alteration in primary hemostatic mechanism. Collet <italic>et al</italic>. stated that in patients on aspirin, the average risk of bleeding increases 1.5-fold. At the same time, there is a risk of stopping aspirin prior to surgery, which leads to a potential risk of rebound of thromboembolic vascular events. On stopping aspirin, thromboxane A2 activity increases to a greater extent with decrease in fibrinolytic activity.[<xref rid="ref11" ref-type="bibr">11</xref>] Anderson <italic>et al</italic>. showed the existence of biological platelet rebound phenomenon on interruption of aspirin therapy. This could create a prothrombotic state which may lead to fatal thromboembolic events. Approximately 20% of these episodes are fatal and another 40% can lead to permanent disability.[<xref rid="ref12" ref-type="bibr">12</xref>]</p><p>Practitioners who advocate the stoppage of aspirin have been debating among themselves regarding the time limit to stop aspirin. According to literature, the effect of aspirin on platelets is irreversible. The effect lasts for 7-10 days which is the life span of platelets.[<xref rid="ref13" ref-type="bibr">13</xref><xref rid="ref14" ref-type="bibr">14</xref>] Therefore, it was recommended to stop aspirin 7 days prior to surgical procedure.[<xref rid="ref15" ref-type="bibr">15</xref><xref rid="ref16" ref-type="bibr">16</xref><xref rid="ref17" ref-type="bibr">17</xref><xref rid="ref18" ref-type="bibr">18</xref><xref rid="ref19" ref-type="bibr">19</xref>] Sonksen <italic>et al</italic>., in their study comprising 52 healthy individuals, reported that it is not recommended to withdraw aspirin for more than 5 days.[<xref rid="ref20" ref-type="bibr">20</xref>] Wahl <italic>et al</italic>. advocated that aspirin should be discontinued for 3 days only, as after 3 days of interruption of aspirin, sufficient number of newer platelets would be present in the circulation for hemostasis.[<xref rid="ref21" ref-type="bibr">21</xref><xref rid="ref22" ref-type="bibr">22</xref>]</p><p>Now again the debate arises whether to stop aspirin therapy or not. Fear for uncontrolled bleeding encourages the practitioners to discontinue aspirin therapy. Some studies have shown that there is always an increased risk of bleeding in patients continuing aspirin.[<xref rid="ref23" ref-type="bibr">23</xref><xref rid="ref24" ref-type="bibr">24</xref>] Hence, some studies recommended stopping of aspirin therapy prior to surgical procedure.[<xref rid="ref17" ref-type="bibr">17</xref><xref rid="ref19" ref-type="bibr">19</xref><xref rid="ref25" ref-type="bibr">25</xref>] However, if the aspirin therapy is discontinued, there is increased risk of thromboembolic events which can be fatal, but none of these have been reported in dental literature. Lawrence <italic>et al</italic>. mentioned in their article that there is scarcity of literature regarding dental surgeries involving patients on aspirin medication.[<xref rid="ref26" ref-type="bibr">26</xref>] Little <italic>et al</italic>. reported that unless the bleeding time is increased above 20 min, aspirin-affected platelets would not cause significant bleeding complication.[<xref rid="ref22" ref-type="bibr">22</xref>] Similar claims were made by Sonksen <italic>et al</italic>. and Gaspar <italic>et al</italic>.[<xref rid="ref20" ref-type="bibr">20</xref><xref rid="ref27" ref-type="bibr">27</xref>]</p><p>Canigral <italic>et al</italic>. conducted a research involving surgical extraction in patients on antithrombotic therapy. In 92% cases, the bleeding stopped within 10 min with pressure alone. This result was in accordance with the present study.[<xref rid="ref4" ref-type="bibr">4</xref>] Gaspar <italic>et al</italic>. advocated that ambulatory oral surgical procedures can be performed in patients without discontinuing the use of aspirin.[<xref rid="ref27" ref-type="bibr">27</xref>] A recent recommendation from the American Heart Association and American College of Cardiology is either continuing aspirin or clopidogrel therapy for minor oral surgical procedures in patients with coronary artery stents or delay the treatment until prescribed regimen is complicated.</p><p>The present study demonstrated that there was significant increase in the bleeding time in both the groups, but it was not difficult to stop the bleeding in any case. Although the bleeding time increased in group A patients, it still remained within the normal range, regardless of whether the patients continued or discontinued their aspirin therapy.[<xref rid="ref28" ref-type="bibr">28</xref><xref rid="ref29" ref-type="bibr">29</xref><xref rid="ref30" ref-type="bibr">30</xref>] This result was similar to that of the study done by Canigral <italic>et al</italic>.[<xref rid="ref4" ref-type="bibr">4</xref>] Valerin <italic>et al</italic>. conducted a study with 17 patients randomized to aspirin and 19 to placebo and found no differences in the bleeding outcomes for patients on aspirin. This finding suggested that there was no need to discontinue aspirin prior to any ambulatory oral surgical procedure.[<xref rid="ref31" ref-type="bibr">31</xref>]</p><p>Adchariyapetch compared the postoperative bleeding in subjects who stopped taking aspirin and those who continued taking aspirin for 7 days prior to extraction. The mean bleeding time in both the groups was in normal range. After the procedure, there was no difficulty in achieving hemostasis. Therefore, they concluded that surgical extraction did not require discontinuation of antiplatelet therapy.[<xref rid="ref32" ref-type="bibr">32</xref>] Matocha concluded in his study that the risk of bleeding after dental extraction is minimal in the patients with aspirin therapy and did not exceed 0.2-2.3%[<xref rid="ref33" ref-type="bibr">33</xref>]</p><p>Murphy <italic>et al</italic>. concluded in their survey that 86% of the dental practitioners who advised patients to stop taking antiplatelet drugs prior to dental extraction did so with the consultation of the patients&#x02019; physicians, and found that the protocol followed by the physicians and dentists was not based on the current recommendations and guidelines.[<xref rid="ref34" ref-type="bibr">34</xref>]</p><p>Valerin <italic>et al</italic>. concluded that the risk of stopping antiplatelet therapy and predisposing the patient to thromboembolic events overweighed the minimal risk of bleeding from dental procedures. Similar results were found in the study done by Nielsen <italic>et al</italic>.[<xref rid="ref35" ref-type="bibr">35</xref>] Wahl reported in his study that of 950 patients receiving anticoagulation therapy, only 12 required (&#x0003c;1.3%) more than local measures to stop the bleeding. He concluded that while discontinuation of anticoagulation therapy has been a common practice, bleeding after dental surgery is rarely life threatening.</p></sec><sec sec-type="conclusion" id="sec1-5"><title>CONCLUSION</title><p>Thus, it can be concluded based on dental and medical literature that if a practitioner wishes to discontinue the aspirin therapy, it should not exceed more than 3 days. Moreover, it should not be done without consulting the physician. Risk of stopping antiplatelet therapy and predisposing the patient to thromboembolic events overweighs the minimal risk of bleeding from dental procedures. Although there was increase in bleeding time in the present study, it was not beyond the normal range. Hence, it can be concluded that low dose of aspirin should not be discontinued prior to dental extractions, as it predisposes the patient to unwanted thromboembolic events.</p></sec></body><back><fn-group><fn fn-type="supported-by"><p><bold>Source of Support:</bold> Nil</p></fn><fn fn-type="conflict"><p><bold>Conflict of Interest:</bold> None declared.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jafri</surname><given-names>SM</given-names></name><name><surname>Zarowitz</surname><given-names>B</given-names></name><name><surname>Goldstein</surname><given-names>S</given-names></name><name><surname>Lesch</surname><given-names>M</given-names></name></person-group><article-title>The role of antiplatelet therapy in acute coronary syndromes and for secondary prevention following a myocardial infarction</article-title><source>Prog Cardiovasc Dis</source><year>1993</year><volume>36</volume><fpage>75</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">8321905</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Owens</surname><given-names>CD</given-names></name><name><surname>Belkin</surname><given-names>M</given-names></name></person-group><article-title>Thrombosis and coagulation: Operative management of the anticoagulated patient</article-title><source>Surg Clin North Am</source><year>2005</year><volume>85</volume><fpage>1179</fpage><lpage>89</lpage><comment>x</comment><pub-id pub-id-type="pmid">16326201</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>M</given-names></name><name><surname>Dave</surname><given-names>D</given-names></name><name><surname>Dave</surname><given-names>R</given-names></name><name><surname>Bharwani</surname><given-names>A</given-names></name><name><surname>Shah</surname><given-names>A</given-names></name></person-group><article-title>Management of medically compromised patient in periodontal practice: An overview (Part 1)</article-title><source>Adv Hum Biol</source><year>2013</year><volume>3</volume><fpage>1</fpage><lpage>6</lpage></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ca&#x000f1;igral</surname><given-names>A</given-names></name><name><surname>Silvestre</surname><given-names>FJ</given-names></name><name><surname>Ca&#x000f1;igral</surname><given-names>G</given-names></name><name><surname>Al&#x000f3;s</surname><given-names>M</given-names></name><name><surname>Garcia-Herraiz</surname><given-names>A</given-names></name><name><surname>Plaza</surname><given-names>A</given-names></name></person-group><article-title>Evaluation of bleeding risk and measurement methods in dental patients</article-title><source>Med Oral Patol Oral Cir Bucal</source><year>2010</year><volume>15</volume><fpage>e863</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">20711153</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dogne</surname><given-names>JM</given-names></name><name><surname>de Leval</surname><given-names>X</given-names></name><name><surname>Benoit</surname><given-names>P</given-names></name><name><surname>Delarge</surname><given-names>J</given-names></name><name><surname>Masereel</surname><given-names>B</given-names></name><name><surname>David</surname><given-names>JL</given-names></name></person-group><article-title>Recent advances in antiplatelet agents</article-title><source>Curr Med Chem</source><year>2002</year><volume>9</volume><fpage>577</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">11945125</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Craven</surname><given-names>LL</given-names></name></person-group><article-title>Acetylsalicylic acid, possible preventive of coronary thrombosis</article-title><source>Ann West Med Surg</source><year>1950</year><volume>4</volume><fpage>95</fpage><pub-id pub-id-type="pmid">15403207</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brennan</surname><given-names>MT</given-names></name><name><surname>Wynn</surname><given-names>RL</given-names></name><name><surname>Miller</surname><given-names>CS</given-names></name></person-group><article-title>Aspirin and bleeding in dentistry: An update and recommendations</article-title><source>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</source><year>2007</year><volume>104</volume><fpage>316</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">17618144</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patrono</surname><given-names>C</given-names></name><name><surname>Ciabattoni</surname><given-names>G</given-names></name><name><surname>Patrignani</surname><given-names>P</given-names></name><name><surname>Pugliese</surname><given-names>F</given-names></name><name><surname>Filabozzi</surname><given-names>P</given-names></name><name><surname>Catella</surname><given-names>F</given-names></name><etal/></person-group><article-title>Clinical pharmacology of platelet cyclooxygenase inhibition</article-title><source>Circulation</source><year>1985</year><volume>72</volume><fpage>1177</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">3933848</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><collab>Antithrombotic Trialists&#x02019; Collaboration</collab><article-title>Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high
risk patients</article-title><source>BMJ</source><year>2002</year><volume>324</volume><fpage>71</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">11786451</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalen</surname><given-names>JE</given-names></name></person-group><article-title>Aspirin to prevent heart attack and stroke: What's the right dose?</article-title><source>Am J Med</source><year>2006</year><volume>119</volume><fpage>198</fpage><lpage>202</lpage><pub-id pub-id-type="pmid">16490462</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collet</surname><given-names>J</given-names></name><name><surname>Montalescot</surname><given-names>G</given-names></name></person-group><article-title>Premature withdrawal and alternative therapies to dual oral antiplatelet therapy</article-title><source>Eur Heart J Suppl</source><year>2006</year><volume>8</volume><fpage>G46</fpage><lpage>52</lpage></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>CS</given-names></name><name><surname>Jamrozik</surname><given-names>KD</given-names></name><name><surname>Broadhurst</surname><given-names>RJ</given-names></name><name><surname>Stewart-Wynne</surname><given-names>EG</given-names></name></person-group><article-title>Predicting survival for 1 year among different subtypes of stroke: Results from The Perth Community Stroke Study</article-title><source>Stroke</source><year>1994</year><volume>25</volume><fpage>1935</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">8091436</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merritt</surname><given-names>JC</given-names></name><name><surname>Bhatt</surname><given-names>DL</given-names></name></person-group><article-title>The efficacy and safety of perioperative antiplatelet therapy</article-title><source>J Thromb Thrombolysis</source><year>2002</year><volume>13</volume><fpage>97</fpage><lpage>103</lpage><pub-id pub-id-type="pmid">12101387</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schafer</surname><given-names>AI</given-names></name></person-group><article-title>Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis</article-title><source>J Clin Pharmacol</source><year>1995</year><volume>35</volume><fpage>209</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">7608308</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>CJ</given-names></name><name><surname>Deane</surname><given-names>AM</given-names></name><name><surname>Doyle</surname><given-names>PT</given-names></name><name><surname>Bullock</surname><given-names>KN</given-names></name></person-group><article-title>Identifiable factors in post-prostatectomy haemorrhage: The role of aspirin</article-title><source>Br J Urol</source><year>1990</year><volume>66</volume><fpage>85</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">2393802</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitchen</surname><given-names>L</given-names></name><name><surname>Erichson</surname><given-names>RB</given-names></name><name><surname>Sideropoulos</surname><given-names>H</given-names></name></person-group><article-title>Effect of drug-induced platelet dysfunction on surgical bleeding</article-title><source>Am J Surg</source><year>1982</year><volume>143</volume><fpage>215</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">7058991</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conti</surname><given-names>CR</given-names></name></person-group><article-title>Aspirin and elective surgical procedures</article-title><source>Clin Cardiol</source><year>1992</year><volume>15</volume><fpage>709</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">1395180</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scher</surname><given-names>KS</given-names></name></person-group><article-title>Unplanned reoperation for bleeding</article-title><source>Am Surg</source><year>1996</year><volume>62</volume><fpage>52</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">8540646</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Speechley</surname><given-names>JA</given-names></name><name><surname>Rugman</surname><given-names>FP</given-names></name></person-group><article-title>Some problems with anticoagulants in dental surgery</article-title><source>Dent Update</source><year>1992</year><volume>19</volume><fpage>204</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">1289162</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sonksen</surname><given-names>JR</given-names></name><name><surname>Kong</surname><given-names>KL</given-names></name><name><surname>Holder</surname><given-names>R</given-names></name></person-group><article-title>Magnitude and time course of impaired primary haemostasis after stopping chronic low and medium dose aspirin in healthy volunteers</article-title><source>Br J Anaesth</source><year>1999</year><volume>82</volume><fpage>360</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">10434816</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wahl</surname><given-names>MJ</given-names></name></person-group><article-title>Myths of dental surgery in patients receiving anticoagulant therapy</article-title><source>J Am Dent Assoc</source><year>2000</year><volume>131</volume><fpage>77</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">10649877</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Little</surname><given-names>JW</given-names></name><name><surname>Miller</surname><given-names>CS</given-names></name><name><surname>Henry</surname><given-names>RG</given-names></name><name><surname>McIntosh</surname><given-names>BA</given-names></name></person-group><article-title>Antithrombotic agents: Implications in dentistry</article-title><source>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</source><year>2002</year><volume>93</volume><fpage>544</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">12075203</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferraris</surname><given-names>VA</given-names></name><name><surname>Ferraris</surname><given-names>SP</given-names></name><name><surname>Lough</surname><given-names>FC</given-names></name><name><surname>Berry</surname><given-names>WR</given-names></name></person-group><article-title>Preoperative aspirin ingestion increases operative blood loss after coronary artery bypass grafting</article-title><source>Ann Thorac Surg</source><year>1988</year><volume>45</volume><fpage>71</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">3257376</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taggart</surname><given-names>DP</given-names></name><name><surname>Siddiqui</surname><given-names>A</given-names></name><name><surname>Wheatley</surname><given-names>DJ</given-names></name></person-group><article-title>Low-dose preoperative aspirin therapy, postoperative blood loss, and transfusion requirements</article-title><source>Ann Thorac Surg</source><year>1990</year><volume>50</volume><fpage>424</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">2400264</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferraris</surname><given-names>VA</given-names></name><name><surname>Swanson</surname><given-names>E</given-names></name></person-group><article-title>Aspirin usage and perioperative blood loss in patients undergoing unexpected operations</article-title><source>Surg Gynecol Obstet</source><year>1983</year><volume>156</volume><fpage>439</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">6836459</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawrence</surname><given-names>C</given-names></name><name><surname>Sakuntabhai</surname><given-names>A</given-names></name><name><surname>Tiling-Grosse</surname><given-names>S</given-names></name></person-group><article-title>Effect of aspirin and nonsteroidal antiinflammatory drug therapy on bleeding complications in dermatologic surgical patients</article-title><source>J Am Acad Dermatol</source><year>1994</year><volume>31</volume><fpage>988</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">7962782</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaspar</surname><given-names>R</given-names></name><name><surname>Ardekian</surname><given-names>L</given-names></name><name><surname>Brenner</surname><given-names>B</given-names></name><name><surname>Peled</surname><given-names>M</given-names></name><name><surname>Laufer</surname><given-names>D</given-names></name></person-group><article-title>Ambulatory oral procedures in patients on low-dose aspirin</article-title><source>Harefuah</source><year>1999</year><volume>136</volume><fpage>108</fpage><lpage>10</lpage><comment>175</comment><pub-id pub-id-type="pmid">10914173</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burger</surname><given-names>W</given-names></name><name><surname>Chemnitius</surname><given-names>JM</given-names></name><name><surname>Kneissl</surname><given-names>GD</given-names></name><name><surname>R&#x000fc;cker</surname><given-names>G</given-names></name></person-group><article-title>Low-close aspirin for secondary cardiovascular prevention-cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation-review and meta-analysis</article-title><source>J Intern Med</source><year>2005</year><volume>257</volume><fpage>399</fpage><lpage>414</lpage><pub-id pub-id-type="pmid">15836656</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harker</surname><given-names>LA</given-names></name><name><surname>Slichter</surname><given-names>SJ</given-names></name></person-group><article-title>The bleeding time as a screening test for evaluation of platelet function</article-title><source>N Engl J Med</source><year>1972</year><volume>287</volume><fpage>155</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">4537519</pub-id></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>KA</given-names></name><name><surname>Patel</surname><given-names>MA</given-names></name><name><surname>Tatu</surname><given-names>R</given-names></name><name><surname>Patel</surname><given-names>V</given-names></name></person-group><article-title>Relationship between use of aspirin and post-extraction bleeding time: A randomized control and single blind study in fifty patients</article-title><source>J Res Adv Dent</source><year>2013</year><volume>2</volume><fpage>167</fpage><lpage>72</lpage></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valerin</surname><given-names>MA</given-names></name><name><surname>Brennan</surname><given-names>MT</given-names></name><name><surname>Noll</surname><given-names>JL</given-names></name><name><surname>Nape&#x000f1;as</surname><given-names>JJ</given-names></name><name><surname>Kent</surname><given-names>ML</given-names></name><name><surname>Fox</surname><given-names>PC</given-names></name><etal/></person-group><article-title>Relationship between aspirin use and postoperative bleeding from dental extractions in a healthy population</article-title><source>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</source><year>2006</year><volume>102</volume><fpage>326</fpage></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adchariyapetch</surname><given-names>R</given-names></name></person-group><article-title>Dental extraction in patients on aspirin</article-title><source>Vajira Med J</source><year>2009</year><volume>53</volume><fpage>283</fpage><lpage>89</lpage></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matocha</surname><given-names>DL</given-names></name></person-group><article-title>Postsurgical complications</article-title><source>Emerg Med Clin North Am</source><year>2000</year><volume>18</volume><fpage>549</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">10967739</pub-id></element-citation></ref><ref id="ref34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>J</given-names></name><name><surname>Twohig</surname><given-names>E</given-names></name><name><surname>McWilliams</surname><given-names>SR</given-names></name></person-group><article-title>Dentists&#x02019; approach to patients on anti-platelet agents and warfarin: A survey of practice</article-title><source>J Ir Dent Assoc</source><year>2010</year><volume>56</volume><fpage>28</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">20337143</pub-id></element-citation></ref><ref id="ref35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nielsen</surname><given-names>JD</given-names></name><name><surname>Laetgaard</surname><given-names>CA</given-names></name><name><surname>Schou</surname><given-names>S</given-names></name><name><surname>Jensen</surname><given-names>SS</given-names></name></person-group><article-title>Minor dentoalveolar surgery in patients undergoing antithrombotic therapy</article-title><source>Ugeskr Laeger</source><year>2009</year><volume>171</volume><fpage>1407</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">19413940</pub-id></element-citation></ref></ref-list></back></article>